+45 33 75 10 00

info@nordic-labs.com

 

H. Pylori (stand alone)

Recent studies have shown that nearly 50% of the world's population may harbor H. pylori. And, although many carriers are asymptomatic, H. pylori is known to have a causative role in ulcers, chronic gastritis, and stomach cancer.

Additionally, in early phases of colonization, individuals may experience hypochlorhydria followed by a change to hyper aciduria. Over time, additional H. pylori strains may colonize, including those with Virulence Factors and increased disease potential.

This test is also good to use as a follow-up to a GI-MAP test after H. pylori treatment, to monitor successful therapy.